Direct T cell–tumour interaction triggers T(H)1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme

por Jin, P, Civini, S, Zhao, Y, De Giorgi, V, Ren, J, Sabatino, M, Jin, J, Wang, H, Bedognetti, D, Marincola, F, Stroncek, D
Publicado 2014

Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study

por Mandalà, M., Rutkowski, P., Galli, F., Patuzzo, R., De Giorgi, V., Rulli, E., Gianatti, A., Valeri, B., Merelli, B., Szumera-Ciećkiewicz, A., Massi, D., Maurichi, A., Teterycz, P., Santinami, M.
Publicado 2022

Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology

por Queirolo, P., Cinquini, M., Argenziano, G., Bassetto, F., Bossi, P., Boutros, A., Clemente, C., de Giorgi, V., Del Vecchio, M., Patuzzo, R., Peris, K., Quaglino, P., Reali, A., Zalaudek, I., Spagnolo, F.
Publicado 2023

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes

por Murtas, D, Maric, D, De Giorgi, V, Reinboth, J, Worschech, A, Fetsch, P, Filie, A, Ascierto, M L, Bedognetti, D, Liu, Q, Uccellini, L, Chouchane, L, Wang, E, Marincola, F M, Tomei, S
Publicado 2013

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

por Bedognetti, D, Spivey, T L, Zhao, Y, Uccellini, L, Tomei, S, Dudley, M E, Ascierto, M L, De Giorgi, V, Liu, Q, Delogu, L G, Sommariva, M, Sertoli, M R, Simon, R, Wang, E, Rosenberg, S A, Marincola, F M
Publicado 2013